Showing results (11-20 of 232) with videos related to
Sort By:
Pageof 24
Expert Review of Endocrinology & Metabolism|July 31, 2018
IDegAsp (insulin degludec + insulin aspart) for the management of type 2 diabetes: current statusJens Sandahl Christiansen, Philip Home, Ajay KumarDiabetes Technology & Therapeutics|March 20, 2015
An Overview of Current Regulatory Requirements for Approval of Biosimilar InsulinsLutz Heinemann, Hootan Khatami, Ross McKinnon, et al.Health & Place|April 26, 2026
Spatial dynamics of biodiversity and cycling behaviour: A geographical analysis using crowdsourced data from Strava metroPhilip Home, Sabrina L Li, Doreen S BoydDiabetes Research and Clinical Practice|June 27, 2018
2020 vision - An overview of prospects for diabetes management and prevention in the next decadeChih-Yuan Wang, David L Neil, Philip HomeAnnals of the New York Academy of Sciences|December 8, 2006
Cardiovascular risk factors predicting the development of distal symmetrical polyneuropathy in people with type 1 diabetes: A 9-year follow-up studyLatika Sibal, Huong Nai Law, Janice Gebbie, et al.Diabetes Research and Clinical Practice|October 12, 2014
An analysis of the short- and long-term cost-effectiveness of starting biphasic insulin aspart 30 in insulin-naïve people with poorly controlled type 2 diabetesAsrul Akmal Shafie, Vishal Gupta, Ranya Baabbad, et al.Journal of Diabetes Science and Technology|July 12, 2022
Understanding Biosimilar Insulins - Development, Manufacturing, and Clinical TrialsLutz Heinemann, Melanie Davies, Philip Home, et al.Journal of Medical Economics|November 20, 2014
An analysis of the cost-effectiveness of starting insulin detemir in insulin-naïve people with type 2 diabetesPhilip Home, Sei Hyun Baik, Guillermo González Gálvez, et al.Diabetes Care|May 30, 2006
A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetesKjeld Hermansen, Melanie Davies, Taudeusz Derezinski, et al.Pageof 24